Cardioncogeriatria: position paper ANMCO sulla gestione cardioncologica del paziente anziano
Irma Bisceglia(Azienda Ospedaliera San Camillo-Forlanini), Furio Colivicchi(Ospedale San Filippo Neri), Damiana Fiscella, Alice Laudisio(Società Italiana di Cardiologia), Giuseppina Gallucci, Stefania Angela Di Fusco(ASL Roma), Massimiliano Camilli(Università Cattolica del Sacro Cuore), Fabiana Lucà(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Raffaella Mistrulli(Sapienza University of Rome), Michele Massimo Gulizia(Ospedale Garibaldi), Giulia Russo(University of Catania), Domenico Gabrielli(Azienda Ospedaliera San Camillo-Forlanini), Andrea Paccone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Fabio Maria Turazza, Giuseppe Zuccalà(Università Cattolica del Sacro Cuore), Iris Parrini(A. O. Ordine Mauriziano di Torino), Fabrizio Oliva(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Maria Laura Canale(Ospedale Versilia), Chiara Lestuzzi
Cited by 2
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
In silico clinical trials: concepts and early adoptions
|Briefings in Bioinformatics|2018|267
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
|Journal of Cardiovascular Pharmacology|2020|111
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108